144 related articles for article (PubMed ID: 10382944)
1. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
Huang XJ; Wiernik PH; Klein RS; Gallagher RE
Med Oncol; 1999 Apr; 16(1):58-64. PubMed ID: 10382944
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3.
Jiang XH; Wong BC; Yuen ST; Jiang SH; Cho CH; Lai KC; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Jan; 91(2):173-9. PubMed ID: 11146441
[TBL] [Abstract][Full Text] [Related]
3. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.
McCafferty-Grad J; Bahlis NJ; Krett N; Aguilar TM; Reis I; Lee KP; Boise LH
Mol Cancer Ther; 2003 Nov; 2(11):1155-64. PubMed ID: 14617789
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of arsenic trioxide-inducing apoptosis].
Huang X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):258-60. PubMed ID: 11601217
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
Liu Q; Hilsenbeck S; Gazitt Y
Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
[TBL] [Abstract][Full Text] [Related]
9. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.
Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S
Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689
[TBL] [Abstract][Full Text] [Related]
10. TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt.
Szegezdi E; Cahill S; Meyer M; O'Dwyer M; Samali A
Br J Cancer; 2006 Feb; 94(3):398-406. PubMed ID: 16434995
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
Sordet O; Rébé C; Leroy I; Bruey JM; Garrido C; Miguet C; Lizard G; Plenchette S; Corcos L; Solary E
Blood; 2001 Jun; 97(12):3931-40. PubMed ID: 11389037
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
Li X; Ding X; Adrian TE
Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841
[TBL] [Abstract][Full Text] [Related]
14. Activation of PKCalpha downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells.
Shao RG; Cao CX; Pommier Y
J Biol Chem; 1997 Dec; 272(50):31321-5. PubMed ID: 9395460
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53.
Akay C; Gazitt Y
Cell Cycle; 2003; 2(4):358-68. PubMed ID: 12851490
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt.
Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK
Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106
[TBL] [Abstract][Full Text] [Related]
18. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
19. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.
Yedjou C; Tchounwou P; Jenkins J; McMurray R
J Hematol Oncol; 2010 Aug; 3():28. PubMed ID: 20796291
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Ishitsuka K; Ikeda R; Utsunomiya A; Uozumi K; Hanada S; Suzuki S; Takeuchi S; Takatsuka Y; Takeshita T; Ohno N; Arima T
Leuk Lymphoma; 2002 May; 43(5):1107-14. PubMed ID: 12148893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]